Prices delayed by at least 15 minutes | Print
E-Therapeutics PLC (ETX)
ORD 0.1PThis share can be held in a Dealing accountISALifetime ISAJISASIPPand can be used with Dividend reinvestment
Company profile
e-Therapeutics PLC is a drug discovery company. Its ambition is to transform the drug discovery process, leveraging its computational network biology platform (drug discovery) to find novel targets to address mechanisms underpinning complex disease. l company activities are carried out in the UK.
Address
17 Blenheim Office Park
Long Hanborough
Oxfordshire
GBR
OX29 8LN
Telephone
+44 1993880000
Forecast key dates
Name | Key Date |
---|---|
e-Therapeutics PLC Second Quarter Earnings Results for 2025 | 2024-10-25T00:00:00 |
e-Therapeutics PLC Annual General Meeting for 2024 | 2024-07-18T12:30:00 |
e-Therapeutics PLC Fourth Quarter Earnings Results for 2024 | 2024-05-03T00:00:00 |
e-Therapeutics PLC Annual Report for 2024 | 2024-05-01T00:00:00 |
Previous key dates
Name | Key Date |
---|---|
e-Therapeutics PLC Second Quarter Earnings Results for 2024 | 2023-10-26T00:00:00 |
e-Therapeutics PLC Annual General Meeting for 2023 | 2023-07-18T12:30:00 |
e-Therapeutics PLC Fourth Quarter Earnings Results for 2023 | 2023-05-04T00:00:00 |
e-Therapeutics PLC Annual Report for 2023 | 2023-05-01T00:00:00 |
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2024 AJ Bell. All rights reserved.